Guido Valesini Selected Research

Lymphoma (Lymphomas)

7/2020	Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren's syndrome and related lymphoproliferation: results in independent cohorts.
1/2019	STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects.
1/2016	The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients With Sjögren's Syndrome: Comment on the Article by Nocturne et al.
11/2015	Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
6/2014	Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
4/2008	CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guido Valesini Research Topics

Disease

53	Rheumatoid Arthritis 05/2021 - 01/2004
39	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2004
24	Autoimmune Diseases (Autoimmune Disease) 07/2021 - 06/2005
18	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2021 - 06/2005
14	Arthritis (Polyarthritis) 01/2022 - 08/2004
12	Infections 11/2019 - 01/2004
12	Rheumatic Diseases (Rheumatism) 01/2019 - 12/2008
11	Inflammation (Inflammations) 10/2020 - 01/2006
11	Psoriatic Arthritis 01/2020 - 03/2006
9	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 03/2003
9	Necrosis 05/2021 - 10/2007
9	Ankylosing Spondylitis 10/2019 - 04/2005
8	Pain (Aches) 05/2017 - 01/2008
6	Lymphoma (Lymphomas) 07/2020 - 04/2008
6	Adult-Onset Still's Disease 01/2020 - 04/2011
6	Thrombosis (Thrombus) 01/2017 - 06/2005
5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019 - 10/2010
4	Neoplasms (Cancer) 12/2020 - 04/2008
4	Lupus Nephritis 10/2020 - 01/2005
4	Osteoarthritis 01/2020 - 10/2011
4	Myositis (Idiopathic Inflammatory Myopathies) 03/2018 - 01/2013
4	Atherosclerosis 01/2018 - 05/2008
4	Psychotic Disorders (Schizoaffective Disorder) 03/2015 - 01/2004
4	Uveitis 01/2012 - 01/2006
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2006
3	Pericarditis 07/2019 - 07/2012
3	Habitual Abortion (Recurrent Miscarriage) 01/2019 - 10/2010
3	Sjogren's Syndrome (Sjogren Syndrome) 01/2019 - 06/2009
3	Fibromyalgia (Fibrositis) 01/2019 - 02/2008
3	Sialadenitis 01/2019 - 01/2004
3	Cognitive Dysfunction 01/2018 - 01/2012
3	Joint Diseases (Joint Disease) 03/2017 - 01/2004
3	Mental Disorders (Mental Disorder) 11/2016 - 01/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2016 - 08/2009
3	Tuberculosis (Tuberculoses) 05/2016 - 11/2012
3	Chronic Disease (Chronic Diseases) 05/2016 - 08/2011
3	Fatigue 05/2016 - 02/2008
3	Synovitis 03/2015 - 01/2014
3	Vasculitis (Vasculitides) 06/2014 - 01/2006
3	Spondylarthropathies 08/2011 - 04/2005
2	Vascular Diseases (Vascular Disease) 10/2022 - 05/2008
2	Crohn Disease (Crohn's Disease) 05/2019 - 05/2016
2	Exanthema (Rash) 01/2019 - 04/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 11/2014

Drug/Important Bio-Agent (IBA)

41	AntibodiesIBA 01/2019 - 03/2003
25	AutoantibodiesIBA 12/2020 - 03/2003
20	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2005
14	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2013
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 08/2007
9	CytokinesIBA 05/2021 - 06/2007
8	Antiphospholipid AntibodiesIBA 07/2021 - 05/2004
8	Peptides (Polypeptides)IBA 01/2019 - 01/2009
6	Antirheumatic Agents (DMARD)IBA 05/2021 - 12/2008
6	Rheumatoid FactorIBA 01/2020 - 01/2004
6	AutoantigensIBA 01/2019 - 01/2005
6	Etanercept (Enbrel)FDA Link 01/2015 - 01/2008
5	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 01/2013
5	C-Reactive ProteinIBA 01/2020 - 01/2008
5	Anti-Citrullinated Protein AntibodiesIBA 01/2020 - 01/2004
5	AntigensIBA 01/2020 - 06/2005
5	Immunoglobulin G (IgG)IBA 10/2018 - 01/2005
5	Infliximab (Remicade)FDA Link 11/2014 - 04/2005
4	VimentinIBA 01/2019 - 10/2010
4	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2018 - 06/2012
4	Adalimumab (Humira)FDA Link 01/2018 - 01/2008
4	Cardiolipins (Cardiolipin)IBA 01/2017 - 10/2010
4	Interleukin-18 (Interleukin 18)IBA 06/2014 - 01/2004
3	Immunoglobulin M (IgM)IBA 12/2020 - 01/2006
3	EnzymesIBA 01/2020 - 01/2008
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019 - 01/2012
3	EpitopesIBA 01/2019 - 08/2011
3	Immunosuppressive Agents (Immunosuppressants)IBA 08/2018 - 12/2008
3	Anti-Idiotypic AntibodiesIBA 01/2018 - 07/2012
3	Estrogen ReceptorsIBA 01/2018 - 03/2012
3	ChemokinesIBA 03/2017 - 08/2004
3	CryoglobulinsIBA 01/2017 - 06/2014
3	Rituximab (Mabthera)FDA Link 07/2015 - 09/2010
3	anti-endothelial cell antibodyIBA 03/2015 - 01/2004
3	Methotrexate (Mexate)FDA LinkGeneric 06/2010 - 11/2003
2	B-Cell Activating FactorIBA 01/2022 - 11/2019
2	Messenger RNA (mRNA)IBA 10/2020 - 01/2016
2	ImmunosorbentsIBA 01/2020 - 07/2017
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 01/2019
2	Interleukin-1 (Interleukin 1)IBA 01/2020 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2019 - 12/2018
2	OsteopontinIBA 11/2019 - 11/2012
2	Complement System Proteins (Complement)IBA 11/2019 - 12/2014
2	apremilastIBA 11/2019 - 08/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 07/2019 - 08/2011
2	LipidsIBA 01/2019 - 06/2005
2	GlucocorticoidsIBA 01/2019 - 07/2017
2	HMGB1 Protein (HMG1)IBA 01/2019 - 01/2017
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2018 - 12/2014
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2016
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2018 - 01/2012
2	Arginine (L-Arginine)FDA Link 01/2018 - 11/2014

Therapy/Procedure

22	Therapeutics 12/2020 - 01/2008
4	Biological Therapy 01/2015 - 08/2009
2	Immunotherapy 01/2022 - 12/2020
2	Blood Component Removal (Apheresis) 07/2017 - 01/2005